Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,162

Document Document Title
WO/2018/003924A1
Provided is a novel pest control agent, especially a bactericide or a nematicide. An alkynylpyridine-substituted amide compound represented by formula (I) or a salt thereof; and a pest control agent which contains the compound or the sal...  
WO/2017/216709A2
This invention provides for flow and batch synthesis processes for the production of Lamivudine and Emtricitabine, including flow and batch synthesis processes wherein at least of the synthesis steps are conducted in a solvent free envir...  
WO/2017/210794A1
There are provided compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide, as well as uses/methods related thereto, including treatment of diseases and condition associated wit...  
WO/2017/162661A1
The present invention covers 1 /-/-benzo[c/e]isoquinoline-1,3(2/-/)-dione compounds of general formula (I) compounds of general formula (I) : in which R1, R2, R3, R4 and R5 are as defined according to claim 1 and methods of preparing sai...  
WO/2017/144150A2
The present invention relates to a process to produce compounds of the formula (1) which are suitable for use in electronic devices, as well as to intermediate compounds of formula (lnt-1) and compounds of formula (1-1) and (1-2) obtaine...  
WO/2017/144150A3
The present invention relates to a process to produce compounds of the formula (1) which are suitable for use in electronic devices, as well as to intermediate compounds of formula (lnt-1) and compounds of formula (1-1) and (1-2) obtaine...  
WO/2017/146246A1
The purpose of the present invention is to provide a compound having excellent antibacterial activity against Mycobacterium tuberculosis, multidrug-resistant tuberculosis bacteria and/or non-tuberculous acid-fast bacteria. A compound rep...  
WO/2017/137319A1
The present invention relates to compounds of the general formula (I), in which Q, V, T, W, X, Y, and A have the meanings given in the description, and to the use thereof for controlling animal pests.  
WO/2017/139569A1
This invention relates to novel 4,4,5,5,7,7-hexamethyl-5,7-dihydro-4H-thieno[2,3-c]pyranyl compounds, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and th...  
WO/2017/137339A1
The present invention relates to compounds of the general formula (I), where to Q, V, T, W, X, Y, and A have the meanings given in the description, and to the use thereof for controlling animal pests.  
WO/2016/173019A1
The present invention relates to a conjugated compound containing a phenoxathiin structure, a method for preparing same, and an organic electroluminescent diode device. The conjugated compound containing a phenoxathiin structure has a ch...  
WO/2016/165007A1
This invention provides of compounds having structures of Formula A, uses of these compounds for treatment of various indications, including breast cancer, as well as methods of treatment involving these compounds.  
WO/2016/127924A1
The present invention relates to novel tricyclic compounds which can bind to FXR and act as modulators of the FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acce...  
WO/2016/118774A1
The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfuncti...  
WO/2016/097071A1
Described herein are compounds that are estrogen receptor modulators of Formula (I) and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein SERMF is a selective estrogen receptor modulator fragment and with th...  
WO/2016/078584A1
Provided is an emtricitabine purification method. The method comprises: separating out the emtricitabine in the form of emtricitabine benzoate from aqueous solution, and dissociating the benzoate to obtain high purity of the emtricitabin...  
WO/2016/065264A1
Provided herein are compounds of formula (I) and compositions containing the compounds. The compounds and compositions are useful in the methods of treating, amelioration or prophylaxix of diseases associated with Nrf2/ NF-κΒ pathways....  
WO/2016/054805A1
The present invention concerns compounds of Formula I that inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of eryt...  
WO/2016/043558A1
The present invention relates to a compound, wherein the compound comprises at least one structural element A and at least one structural element B, wherein - structural element A is capable of releasing an acid upon exposure to electrom...  
WO/2016/038583A1
The present invention provides compounds of Formula (I) and (II) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provid...  
WO/2016/016118A1
Compounds of theformula (I), wherein X and Y are independently O, S or NR5, R1, R2 and R4 are independently hydrogen, halogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy or C1-C6haloalkoxy, R5 is halogen, cyano, C1-C6alkyl or C1- C6haloalky...  
WO/2015/177110A1
The present invention is concerned with indolin-2-one and l,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives of general formula (I) wherein Ar1 is phenyl, pyridinyl or pyrimidinyl; Ar2 is a 5 or 6 membered heteroaryl group, containing 2...  
WO/2015/174215A1
An actinic ray-sensitive or radiation-sensitive resin composition comprising a photoacid generator and resin (B), said resin composition comprising, as the photoacid generator, at least photoacid generator (A) represented by general form...  
WO/2015/163435A1
Provided are compounds that exhibit an excellent autotaxin (ATX) inhibitory effect, etc. and are efficacious as a prophylactic or therapeutic agent for diseases in which ATX participates. Compounds represented by general formula (I) [whe...  
WO/2015/154039A3
The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided...  
WO/2015/154039A8
The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided...  
WO/2015/144813A1
The present invention relates to N-acylimino compound of formula (I). The invention also relates to the use of the N-acylimino heterocyclic compounds of formula (I), their stereoisomers, their tautomers and their salts, for combating inv...  
WO/2015/125824A1
Provided is a novel noxious organism control agent, particularly a bactericidal agent and a nematicidal agent. An alkynylpyridine-substituted amide compound represented by formula (I), an N-oxide of the compound, or a salt of the compoun...  
WO/2015/103526A1
Disclosed are PARP-1 inhibitors, which can be 18 F-labeled for use as tracers in positron emission tomographic (PET) imaging. Further disclosed are methods of synthesis. Of the compounds synthesized, 2-[p-(2-Fluoroethoxy)phenyl]-1.3.10-t...  
WO/2015/089220A1
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.  
WO/2015/089027A1
There is provided a hole transport material having Formula I, Formula Ia, or Formula II: In the formulae: A is an aromatic moiety including at least one triarylamino group; B' is an aromatic moiety; E is an end group which is H, D, alkyl...  
WO/2015/080182A1
A compound that is represented by general formula (1), the compound being useful as a light-emitting material. X represents SO2, P(=O)(Ar1), Ge(Ar2)(Ar3), Si(Ar4)(Ar5), or Sn(Ar6)(Ar7), and Ar1-Ar7 each independently represents a substit...  
WO/2015/051766A1
The present invention relates to amide substituted indazoles and benzotriazoles which are inhibitors of the enzyme poly (ADP-ribose) polymerase (PARP), previously known as poly (ADP-ribose) synthase and poly (ADP-ribosyl) transferase. Th...  
WO/2015/036560A1
The invention relates to novel heterocyclic substituted 6-(trifluoromethyl)pyrimidine- 4(3H)-one derivatives, to a method for the production thereof, to the use thereof either alone or in combination for the treatment and/or prevention o...  
WO/2015/028989A1
The invention relates to novel heterocyclic compounds of the Formula I. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more compounds of...  
WO/2015/031295A1
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, vi...  
WO/2015/030057A1
A morpholine derivative represented by general formula [1A] or a salt thereof. In the formula, the ring A represents a ring represented by general formula [I] or the like; * represents a binding position; Z2 represents CH or the like; Z1...  
WO/2015/008872A1
This invention relates to a cyanotriazole compound represented by the formula (1):, wherein each symbols are defined in the specification, or a salt thereof. The compound or a salt thereof stimulates the citric acid cycle activity and/or...  
WO/2014/206922A1
This invention relates to novel sulfoximine substituted quinazoline derivatives of formula (I) wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1 a or MNK1 b) and/or MNK2 (MNK2a or MNK2b) kina...  
WO/2014/205592A1
Compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV in...  
WO/2014/174532A2
The present invention provides an improved process for the preparation of emtricitabine with high yield and purity.  
WO/2014/174532A3
The present invention provides an improved process for the preparation of emtricitabine with high yield and purity.  
WO/2014/153214A1
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity. Methods of using...  
WO/2014/141035A3
Provided are substituted heterocyclyl derivatives of formula (I), which may be the therapeutically useful, more particularly as NAMPT inhibitors; in which R 1, R 2, X 1, X 2, ring A, L and 'n' have the meanings given in the specification...  
WO/2014/135495A1
The present invention discloses compounds of Formula I: wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of F...  
WO/2014/130565A1
The present invention relates to substituted diaryl azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.  
WO/2014/124092A3
The present disclosure relates to novel crystalline salt forms of lamivudine, methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of viruses such as Human Immunodeficiency Virus (HIV) ...  
WO/2014/079356A1
Emtricitabine sylicylate crystalline, preparing methods and uses thereof are disclosed. The chemical structure of emtricitabine sylicylate is shown in formula 2, wherein, when n=0, formula 2 represents anhydrous emtricitabine sylicylate,...  
WO/2014/061991A1
The present invention relates to a novel organic electroluminescent compound and an organic electroluminescent device containing the same. By using the organic electroluminescent compound according to the present invention, an organic el...  
WO/2014/044738A1
The present invention relates to benzoimidazole-carboxylic acid amide compounds of the formula I, in which R', R", R"', R1, R2, R3, R4, R5, R6 and Z are defined as indicated below. The compounds of the formula I are APJ receptor modulato...  

Matches 1 - 50 out of 1,162